Pharsight

Kadcyla patents expiration

List of large molecules

Patent Number Company Patent Title Patent Expiry Activity Alert
US7097840 NA Methods of treatment using anti-ErbB antibody-maytansinoid conjugates
Jul, 2026

(2 years from now)

Ingredients: ADO-TRASTUZUMAB

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic